[Comment] Antipsychotics for older adults with schizophrenia

Schizophrenia is a chronic and relapsing psychiatric disorder that is now the third most common cause of disability-adjusted life years among older adults (aged ≥60 years).1 The estimated prevalence rate of schizophrenia among older adults is approximately 0·1–0·5%.2 Given the global population increase of older adults, there will be approximately 10 million older individuals with schizophrenia worldwide by 2050.1 Despite this population growth, data on these individuals are scarce, with only 1% of scientific literature on schizophrenia devoted to this population.